1. Home
  2. TIVC vs ENTO Comparison

TIVC vs ENTO Comparison

Compare TIVC & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • ENTO
  • Stock Information
  • Founded
  • TIVC 2016
  • ENTO 2014
  • Country
  • TIVC United States
  • ENTO United States
  • Employees
  • TIVC N/A
  • ENTO N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • ENTO Health Care
  • Exchange
  • TIVC Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • TIVC 2.1M
  • ENTO 2.5M
  • IPO Year
  • TIVC 2021
  • ENTO 2016
  • Fundamental
  • Price
  • TIVC $3.25
  • ENTO $0.41
  • Analyst Decision
  • TIVC
  • ENTO
  • Analyst Count
  • TIVC 0
  • ENTO 0
  • Target Price
  • TIVC N/A
  • ENTO N/A
  • AVG Volume (30 Days)
  • TIVC 98.8K
  • ENTO 98.4K
  • Earning Date
  • TIVC 03-21-2025
  • ENTO 05-20-2025
  • Dividend Yield
  • TIVC N/A
  • ENTO N/A
  • EPS Growth
  • TIVC N/A
  • ENTO N/A
  • EPS
  • TIVC N/A
  • ENTO N/A
  • Revenue
  • TIVC $780,000.00
  • ENTO N/A
  • Revenue This Year
  • TIVC N/A
  • ENTO N/A
  • Revenue Next Year
  • TIVC N/A
  • ENTO N/A
  • P/E Ratio
  • TIVC N/A
  • ENTO N/A
  • Revenue Growth
  • TIVC N/A
  • ENTO N/A
  • 52 Week Low
  • TIVC $2.43
  • ENTO $0.19
  • 52 Week High
  • TIVC $31.45
  • ENTO $4.23
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 42.63
  • ENTO 37.79
  • Support Level
  • TIVC $2.43
  • ENTO $0.39
  • Resistance Level
  • TIVC $3.58
  • ENTO $0.61
  • Average True Range (ATR)
  • TIVC 0.40
  • ENTO 0.07
  • MACD
  • TIVC 0.04
  • ENTO -0.01
  • Stochastic Oscillator
  • TIVC 52.91
  • ENTO 8.93

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: